236 related articles for article (PubMed ID: 34758303)
1. Distinct regulation of tonic GABAergic inhibition by NMDA receptor subtypes.
Wu K; Castellano D; Tian Q; Lu W
Cell Rep; 2021 Nov; 37(6):109960. PubMed ID: 34758303
[TBL] [Abstract][Full Text] [Related]
2. Individual NMDA receptor GluN2 subunit signaling domains differentially regulate the postnatal maturation of hippocampal excitatory synaptic transmission and plasticity but not dendritic morphology.
Keith RE; Wild GA; Keith MJ; Chen D; Pack S; Dumas TC
Synapse; 2024 Jul; 78(4):e22292. PubMed ID: 38813758
[TBL] [Abstract][Full Text] [Related]
3. NYX-2925 induces metabotropic N-methyl-d-aspartate receptor (NMDAR) signaling that enhances synaptic NMDAR and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor.
Bowers MS; Cacheaux LP; Sahu SU; Schmidt ME; Sennello JA; Leaderbrand K; Khan MA; Kroes RA; Moskal JR
J Neurochem; 2020 Mar; 152(5):523-541. PubMed ID: 31376158
[TBL] [Abstract][Full Text] [Related]
4. Long-term α5 GABA A receptor negative allosteric modulator treatment reduces NMDAR-mediated neuronal excitation and maintains basal neuronal inhibition.
Nuwer JL; Povysheva N; Jacob TC
Neuropharmacology; 2023 Oct; 237():109587. PubMed ID: 37270156
[TBL] [Abstract][Full Text] [Related]
5. The glutamate receptor GluN2 subunit regulates synaptic trafficking of AMPA receptors in the neonatal mouse brain.
Hamada S; Ogawa I; Yamasaki M; Kiyama Y; Kassai H; Watabe AM; Nakao K; Aiba A; Watanabe M; Manabe T
Eur J Neurosci; 2014 Oct; 40(8):3136-46. PubMed ID: 25131300
[TBL] [Abstract][Full Text] [Related]
6. Sustained treatment with an α5 GABA A receptor negative allosteric modulator delays excitatory circuit development while maintaining GABAergic neurotransmission.
Nuwer JL; Brady ML; Povysheva NV; Coyne A; Jacob TC
Neuropharmacology; 2021 Oct; 197():108724. PubMed ID: 34284042
[TBL] [Abstract][Full Text] [Related]
7. Differential Nanoscale Topography and Functional Role of GluN2-NMDA Receptor Subtypes at Glutamatergic Synapses.
Kellermayer B; Ferreira JS; Dupuis J; Levet F; Grillo-Bosch D; Bard L; Linarès-Loyez J; Bouchet D; Choquet D; Rusakov DA; Bon P; Sibarita JB; Cognet L; Sainlos M; Carvalho AL; Groc L
Neuron; 2018 Oct; 100(1):106-119.e7. PubMed ID: 30269991
[TBL] [Abstract][Full Text] [Related]
8. Protein Kinase C-Mediated Phosphorylation and α2δ-1 Interdependently Regulate NMDA Receptor Trafficking and Activity.
Zhou MH; Chen SR; Wang L; Huang Y; Deng M; Zhang J; Zhang J; Chen H; Yan J; Pan HL
J Neurosci; 2021 Jul; 41(30):6415-6429. PubMed ID: 34252035
[No Abstract] [Full Text] [Related]
9. NMDA receptors in GABAergic synapses during postnatal development.
Cserép C; Szabadits E; Szőnyi A; Watanabe M; Freund TF; Nyiri G
PLoS One; 2012; 7(5):e37753. PubMed ID: 22662211
[TBL] [Abstract][Full Text] [Related]
10. Activity-dependent control of NMDA receptor subunit composition at hippocampal mossy fibre synapses.
Carta M; Srikumar BN; Gorlewicz A; Rebola N; Mulle C
J Physiol; 2018 Feb; 596(4):703-716. PubMed ID: 29218821
[TBL] [Abstract][Full Text] [Related]
11. CDKL5 controls postsynaptic localization of GluN2B-containing NMDA receptors in the hippocampus and regulates seizure susceptibility.
Okuda K; Kobayashi S; Fukaya M; Watanabe A; Murakami T; Hagiwara M; Sato T; Ueno H; Ogonuki N; Komano-Inoue S; Manabe H; Yamaguchi M; Ogura A; Asahara H; Sakagami H; Mizuguchi M; Manabe T; Tanaka T
Neurobiol Dis; 2017 Oct; 106():158-170. PubMed ID: 28688852
[TBL] [Abstract][Full Text] [Related]
12. Early expression of GluN2A-containing NMDA receptors in a model of fragile X syndrome.
Banke TG; Traynelis SF; Barria A
J Neurophysiol; 2024 Apr; 131(4):768-777. PubMed ID: 38380828
[TBL] [Abstract][Full Text] [Related]
13. Interplay between NMDA receptor dynamics and the synaptic proteasome.
Ferreira JS; Kellermayer B; Carvalho AL; Groc L
Eur J Neurosci; 2021 Sep; 54(6):6000-6011. PubMed ID: 34405467
[TBL] [Abstract][Full Text] [Related]
14. Modulating the Balance of Synaptic and Extrasynaptic NMDA Receptors Shows Positive Effects against Amyloid-β-Induced Neurotoxicity.
Huang Y; Shen W; Su J; Cheng B; Li D; Liu G; Zhou WX; Zhang YX
J Alzheimers Dis; 2017; 57(3):885-897. PubMed ID: 28269783
[TBL] [Abstract][Full Text] [Related]
15. NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (Aβ) overexpressing mice.
Müller MK; Jacobi E; Sakimura K; Malinow R; von Engelhardt J
Acta Neuropathol Commun; 2018 Oct; 6(1):110. PubMed ID: 30352630
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the GluN2A and GluN2B subunits in synaptic and extrasynaptic N-methyl-D-aspartate receptor function and neuronal excitotoxicity.
Zhou X; Ding Q; Chen Z; Yun H; Wang H
J Biol Chem; 2013 Aug; 288(33):24151-9. PubMed ID: 23839940
[TBL] [Abstract][Full Text] [Related]
17. In developing hippocampal neurons, NR2B-containing N-methyl-D-aspartate receptors (NMDARs) can mediate signaling to neuronal survival and synaptic potentiation, as well as neuronal death.
Martel MA; Wyllie DJ; Hardingham GE
Neuroscience; 2009 Jan; 158(1):334-43. PubMed ID: 18378405
[TBL] [Abstract][Full Text] [Related]
18. Synaptic NMDA receptors in basolateral amygdala principal neurons are triheteromeric proteins: physiological role of GluN2B subunits.
Delaney AJ; Sedlak PL; Autuori E; Power JM; Sah P
J Neurophysiol; 2013 Mar; 109(5):1391-402. PubMed ID: 23221411
[TBL] [Abstract][Full Text] [Related]
19. High Salt Intake Recruits Tonic Activation of NR2D Subunit-Containing Extrasynaptic NMDARs in Vasopressin Neurons.
Neupane C; Sharma R; Pai YH; Lee SY; Jeon BH; Kim HW; Stern JE; Park JB
J Neurosci; 2021 Feb; 41(6):1145-1156. PubMed ID: 33303677
[TBL] [Abstract][Full Text] [Related]
20. NMDA Receptors Containing GluN2B/2C/2D Subunits Mediate an Increase in Glutamate Release at Hippocampal CA3-CA1 Synapses.
Prius-Mengual J; Pérez-Rodríguez M; Andrade-Talavera Y; Rodríguez-Moreno A
Mol Neurobiol; 2019 Mar; 56(3):1694-1706. PubMed ID: 29916144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
